UCB and Antengene enter global license agreement for ATG-201, a B cell-depleting bispecific antibody
UCB obtains worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting B cell-related autoimmune diseases Deal ...
Under the terms of the Purchase Agreement, BriaPro gains the worldwide rights to develop and commercialize sCD80 as a therapeutic agent for the treatment of cancer, while UMBC holds all rights, title ...
TOKYO, JAPAN, February 10, 2026 /EINPresswire.com/ — Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519, hereafter “Chugai”) and Araris Biotech AG (hereafter ...
Super Bowl LX injury report: Seahawks and Patriots enter title game with key players cleared to play
Both the Seattle Seahawks and New England Patriots head into Super Bowl LX largely healthy after closing out final practices. Quarterbacks Sam Darnold and Drake Maye carry no injury designations.
BOSTON, Feb. 3, 2026 /PRNewswire/ -- ZipBio, a biotechnology company pioneering AI-driven protein therapeutics, announced an exclusive license agreement with MeiraGTx Holdings plc (Nasdaq: MGTX), a ...
Credo Technology Group Holding Ltd (Credo) (NASDAQ: CRDO), an innovator in providing secure, high-speed connectivity solutions that deliver improved reliability and energy efficiency, has entered into ...
SAN JOSE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the technology company known for developing foundational innovations that enable next-generation solutions for the ...
New Illinois law raises age for road test for renewal from 79 to 87 years old. Illinois law effective July 1, 2026 raises in-person renewal age from 75 to 79. Immediate family can report unsafe ...
SEOUL, South Korea, Nov. 24, 2025 /PRNewswire/ -- ToolGen Inc. (KOSDAQ: 199800), a leading genome editing company based in Korea, announced today that it has entered into a strategic cross-license ...
Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results